We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
-2.67%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.06B
AUM Growth
-$221M
(-9.7%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
18.33%
Holding
249
New
38
Increased
87
Reduced
99
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AAR Corp
AIR
|
+$23.4M |
| 2 |
RadNet
RDNT
|
+$13.8M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$13.8M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
+$13M |
| 5 |
Savers
SVV
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$32.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$27.5M |
| 3 |
Planet Fitness
PLNT
|
+$27.5M |
| 4 |
Super Micro Computer
SMCI
|
+$17.1M |
| 5 |
Petco
WOOF
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.32% |
| 2 | Industrials | 21.96% |
| 3 | Technology | 19.12% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Copart
CPRT
$25.9B
| $260K | 0.01% |
+6,024
| New | +$268K |
|
202
Dick's Sporting Goods
DKS
$18.4B
| $257K | 0.01% |
2,370
-8,073
| -77% | -$1.02M |
|
203
Unity
U
$12.5B
| $250K | 0.01% |
7,952
-172
| -2% | -$6.62K |
|
204
Targa Resources
TRGP
$60.4B
| $228K | 0.01% |
2,656
-54
| -2% | -$4.47K |
|
205
Fabrinet
FN
$17.1B
| $217K | 0.01% |
+1,304
| New | +$181K |
|
206
DexCom
DXCM
$27.6B
| $199K | 0.01% |
2,135
-46
| -2% | -$5.18K |
|
207
Etsy
ETSY
$7.65B
| $198K | 0.01% |
3,065
-65
| -2% | -$5.13K |
|
208
Mercury Systems
MRCY
$6.2B
| $194K | 0.01% |
5,223
-190,854
| -97% | -$7.04M |
|
209
Bausch + Lomb
BLCO
$5.77B
| $194K | 0.01% |
11,420
-254
| -2% | -$4.75K |
|
210
Steris
STE
$20.9B
| $172K | 0.01% |
+783
| New | +$177K |
|
211
MarketAxess Holdings
MKTX
$4.15B
| $164K | 0.01% |
768
-10
| -1% | -$2.42K |
|
212
Madrigal Pharmaceuticals
MDGL
$12.6B
| $128K | 0.01% |
878
-60,605
| -99% | -$11.4M |
|
213
EPAM Systems
EPAM
$4.69B
| $113K | 0.01% |
+440
| New | +$109K |
|
214
Enterprise Financial Services Corp
EFSC
$2.41B
| $66.9K | ﹤0.01% |
+1,783
| New | +$71.1K |
|
215
Ocular Therapeutix
OCUL
$1.86B
| $65.2K | ﹤0.01% |
20,768
-24,949
| -55% | -$102K |
|
216
First Commonwealth Financial
FCF
$2.12B
| $49.4K | ﹤0.01% |
+4,044
| New | +$53.3K |
|
217
Salesforce
CRM
$134B
| $40.6K | ﹤0.01% |
+200
| New | +$43.2K |
|
218
Citizens & Northern Corp
CZNC
$436M
| $40.4K | ﹤0.01% |
+2,300
| New | +$44.5K |
|
219
Kinsale Capital Group
KNSL
$7.95B
| $32.7K | ﹤0.01% |
+79
| New | +$30.7K |
|
220
SBA Communications
SBAC
$18.4B
| $31K | ﹤0.01% |
+155
| New | +$34.5K |
|
221
American Tower
AMT
$77.7B
| $28.8K | ﹤0.01% |
+175
| New | +$32K |
|
222
Alkermes
ALKS
$8.82B
| $27.4K | ﹤0.01% |
+980
| New | +$28.7K |
|
223
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $27.3K | ﹤0.01% |
+407
| New | +$27.5K |
|
|
PACW
224
DELISTED
PacWest Bancorp
PACW
| $23.9K | ﹤0.01% |
+3,026
| New | +$25.2K |
|
225
Five Below
FIVE
$11.2B
| $23.8K | ﹤0.01% |
+148
| New | +$27.1K |
|
Similar funds
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
FAM
Emerald Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Emerald Advisers held 249 positions worth $2.06B, down 9.7% from $2.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Advisers's Q3 2023 filing shows 38 new, 87 increased, 99 reduced and 17 closed positions. Its largest new stake was RadNet: 443,538 shares worth $12.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $32.3M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.
- Emerald Advisers's largest Q3 2023 buy was RadNet: 443,538 shares worth $12.5M.
- Emerald Advisers added most to AAR Corp in Q3 2023, an estimated $23.4M increase.
- Emerald Advisers's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $17.1M.
- Emerald Advisers fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $32.3M.
- Emerald Advisers's ten largest holdings make up 18% of its $2.06B portfolio in Q3 2023.
- Emerald Advisers opened 38 new positions and closed 17 in Q3 2023.
- Emerald Advisers's portfolio value fell 9.7% quarter-over-quarter to $2.06B.
Based on Emerald Advisers's 13F filing for Q3 2023, filed 26 Oct 2023.